Related Experiment Video
Updated: Aug 5, 2026
19:16
The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
Published on: March 18, 2010
[Cathepsin B and pro-drug activation]
1Katedra i Zakład Biochemii Farmaceutycznej Akademii Medycznej we Wrocławiu. warwas@bf.uni.wroc.pl
Postepy Higieny I Medycyny Doswiadczalnej
|March 9, 2004
Summary
Cathepsin B (CB) is a key enzyme in cancer invasion. New anticancer therapies leverage CB to activate pro-drugs, enhancing tumor targeting and diagnostic potential.
Area of Science:
- Biochemistry
- Oncology
- Enzymology
Context:
- Cathepsin B (CB) is a cysteine peptidase linked to tumor progression.
- CB's role in cancer invasion involves proteolytic cascades.
- Targeting CB offers a strategy for selective cancer therapy.
Purpose:
- To review anticancer therapy strategies utilizing CB as a specific activator.
- To explore Antibody Directed Enzyme Pro-Drug Therapy (ADEPT) and Polymer Directed Enzyme Pro-Drug Therapy (PDEPT).
- To discuss the diagnostic utility of CB in neoplastic diseases.
Summary:
- This paper details current knowledge on using CB-activated pro-drugs for cancer treatment.
- It covers Antibody Directed Enzyme Pro-Drug Therapy and Polymer Directed Enzyme Pro-Drug Therapy approaches.
- The diagnostic value of measuring CB levels in cancer patients is also examined.
Impact:
- Pro-drugs activated by CB show potential for enhanced tumor selectivity.
- CB-activated therapies offer a targeted approach to cancer treatment.
- CB determination aids in the laboratory diagnosis of cancers.
More Related Videos
10:26Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions
Published on: December 20, 2017
07:22The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)
Published on: January 12, 2024
Related Concept Videos
01:24Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
01:16Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
01:14Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:30Prodrugs
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
01:28Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...